TITLE

AN EVALUATION OF FIBRINOLYSIN THERAPY IN ACUTE MYOCARDIAL INFARCTION

AUTHOR(S)
Richter, Isaac H.; Epstein, Samuel; Cliffton, Eugene
PUB. DATE
February 1969
SOURCE
Angiology;Feb1969, Vol. 20 Issue 2, p95
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
In 182 hospitalized patients given fibrinolysin and anticoagulants, the rate of mortality following acute myocardial infarction was lower than the rate observed with anticoagulants alone. One million or more M.S.D. units of fibrinolysin was the most effective dose studied for maximum improvement in mortality rate. Side effects in the fibrinolysin-treated group were similar to those seen in the control group
ACCESSION #
16398108

 

Related Articles

  • Dabigatran associated with increased MI risk.  // Pulse;1/18/2012, Vol. 72 Issue 2, p13 

    The article offers information on the results of a new meta-analysis headed by neurologist Dr. Ken Uchino which highlight the association of anticoagulant dabigatran with an increased risk of myocardial infarction (MI) or acute coronary syndrome.

  • Aspirin withdrawal.  // Reactions Weekly;4/11/2009, Issue 1247/1248, p7 

    The article describes the case of a 65-year-old man with a history of inferior stent thrombosis (ST)-elevation myocardial infarction (STEMI) who developed very late thrombosis of a bare metal stent after discontinuing aspirin antiplatelet therapy. He received intracoronary abciximab and...

  • Trastuzumab.  // Reactions Weekly;Sep2014, Vol. 1520 Issue 1, p208 

    The article presents a case study of a woman patient who developed cardiotoxicity and died of myocardial infarction after receiving trastuzumab for breast cancer.

  • PLATELET INHIBITORS.  // Complete Guide to Prescription & Nonprescription Drugs 2012;2008, p670 

    The article presents information on platelet inhibitors, the antithrombotic agents used for reducing the risk of heart attack or stroke. The dosage and usage information is provided. The possible adverse reactions or side effects of the drugs, warnings, and precautions are discussed. Possible...

  • Aspirin.  // Reactions Weekly;8/29/2009, Issue 1267, p8 

    The article presents the cases of two men who developed spontaneous perirenal haematomas while receiving aspirin for antiplatelet therapy. The first patient, a 57-year-old man with a history of acute coronary syndrome, reported a constant left flank pain for 6 hours that radiated to his left...

  • Risk of death in abrupt clopidogrel cessation. Praities, Nigel // Pulse;2/13/2008, Vol. 68 Issue 5, p10 

    The article focuses on the issue concerning the adverse effect of abrupt cessation in using clopidogrel, a potent oral antiplatelet agent used in treating coronary artery disease. It reports that patients who are abruptly taken off clopidogrel are vulnerable to risk of a myocardial infarction or...

  • Oral Anticoagulant + Antiplatelet Therapy = Danger. Elliott, William T. // Clinical Cardiology Alert;Sep2007 Supplement, Vol. 26, p1 

    The article discusses research being done on the adverse effect of taking antiplatelet drugs with oral anticoagulants. It references a study published in a 2007 issue of "New England Journal of Medicine." The study of 2,100 peripheral artery disease (PAD) patients reveals that the first...

  • PLATELET INHIBITORS.  // Complete Guide to Prescription & Nonprescription Drugs 2012;2007, p672 

    The article presents information on platelet inhibitors, the antithrombotic agents used for reducing the risk of heart attack or stroke. The dosage and usage information is provided. The possible adverse reactions or side effects of the drugs, warnings, and precautions are discussed. Possible...

  • Heparin.  // Reactions Weekly;3/14/2009, Issue 1243, p25 

    The article describes a case of thrombocytopenia complicated by thrombosis induced by heparin therapy. A 72-year-old man started receiving heparin after suffering from acute myocardial infarction during coronary bypass. It outlines the symptoms experienced by the patient after three days of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics